Related references
Note: Only part of the references are listed.Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
Hsing-Chen Tsai et al.
CANCER CELL (2012)
Many stimuli pull the necrotic trigger, an overview
N. Vanlangenakker et al.
CELL DEATH AND DIFFERENTIATION (2012)
Drug resistance in the mouse cancer clinic
Sven Rottenberg et al.
DRUG RESISTANCE UPDATES (2012)
Clinical trials unite mice and humans
Leisa Johnson
NATURE (2012)
DRUG DISCOVERY Cell lines battle cancer
John N. Weinstein
NATURE (2012)
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
Metamia Ciampricotti et al.
NATURE MEDICINE (2012)
Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses
Naokazu Chiba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
Kelley S. Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseases
Zhe-Sheng Chen et al.
FEBS JOURNAL (2011)
Differentiated Human Colorectal Cancer Cells Protect Tumor-Initiating Cells From Irinotecan
Benjamin L. Emmink et al.
GASTROENTEROLOGY (2011)
Multifactorial Approach to Predicting Resistance to Anthracyclines
Christine Desmedt et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Studying Therapy Response and Resistance in Mouse Models for BRCA1-Deficient Breast Cancer
Ewa Malgorzata Michalak et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
TRANSLATIONAL MEDICINE Cancer lessons from mice to humans
David Tuveson et al.
NATURE (2011)
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition
Cihangir Duy et al.
NATURE (2011)
Microenvironmental regulation of stem cells in intestinal homeostasis and cancer
Jan Paul Medema et al.
NATURE (2011)
Programmed necrosis: backup to and competitor with apoptosis in the immune system
Jiahuai Han et al.
NATURE IMMUNOLOGY (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Harnessing synthetic lethal interactions in anticancer drug discovery
Denise A. Chan et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Jean-Pierre Gillet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Asymmetric cancer cell division regulated by AKT
Ipsita Dey-Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Combining Targeted Drugs To Stop Resistant Tumors
Jocelyn Kaiser
SCIENCE (2011)
Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Mickael Michaud et al.
SCIENCE (2011)
GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs
Adrian C. Begg et al.
NATURE REVIEWS CANCER (2011)
Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity
David J. Drasin et al.
BREAST CANCER RESEARCH (2011)
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
Elsa Quintana et al.
CANCER CELL (2010)
Sensitivity and Acquired Resistance of BRCA1;p53-Deficient Mouse Mammary Tumors to the Topoisomerase I Inhibitor Topotecan
Serge A. L. Zander et al.
CANCER RESEARCH (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1; p53-deficient mammary tumor cells in vivo
Marina Pajic et al.
CELL CYCLE (2010)
Cycling toward Elimination of Leukemic Stem Cells
Daniel Goff et al.
CELL STEM CELL (2010)
Prospective Comparison of Clinical and Genomic Multivariate Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer
Jae K. Lee et al.
CLINICAL CANCER RESEARCH (2010)
The therapeutic promise of the cancer stem cell concept
Natasha Y. Frank et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Clinical Experience With Hedgehog Pathway Inhibitors
Jennifer A. Low et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Targeting leukemic stem cells by breaking their dormancy
Marieke Alida Gertruda Essers et al.
MOLECULAR ONCOLOGY (2010)
Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death
Panagiota A. Sotiropoulou et al.
NATURE CELL BIOLOGY (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Identification of Compounds Selectively Killing Multidrug-Resistant Cancer Cells
Dora Tuerk et al.
CANCER RESEARCH (2009)
Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
Marina Pajic et al.
CANCER RESEARCH (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
Cancer Stem Cells: Controversial or Just Misunderstood?
Craig T. Jordan
CELL STEM CELL (2009)
Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes
Stefanie Hauswald et al.
CLINICAL CANCER RESEARCH (2009)
ABC Transporters, Drug Resistance, and Cancer Stem Cells
Michael Dean
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
IFNα activates dormant haematopoietic stem cells in vivo
Marieke A. G. Essers et al.
NATURE (2009)
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery
Bin-Bing S. Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
How do real tumors become resistant to cisplatin?
Piet Borst et al.
CELL CYCLE (2008)
Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: Need for international harmonization in terminology
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Topoisomerase levels determine chemotherapy response in vitro and in vivo
Darren J. Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
Denis M. Schewe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
Neil P. Shah et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Initiation of high frequency multi-drug resistance following kinase targeting by siRNAs
Charles Swanton et al.
CELL CYCLE (2007)
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Chemotherapy dose - response relationships in non-small cell lung cancer and implied resistance mechanisms
David J. Stewart et al.
CANCER TREATMENT REVIEWS (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Characterization of gene rearrangements leading to activation of MDR-1
Lyn M. Huff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
B. Evers et al.
ONCOGENE (2006)
Transmembrane transport of endo- and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins
Roger G. Deeley et al.
PHYSIOLOGICAL REVIEWS (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Generation of a functional mammary gland from a single stem cell
M Shackleton et al.
NATURE (2006)
Why therapeutic response may not prolong the life of a cancer patient - Selection for oncogenic resistance
MV Blagosklonny
CELL CYCLE (2005)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
J Hannemann et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Opinion - The role of apoptosis in cancer development and treatment response
JM Brown et al.
NATURE REVIEWS CANCER (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
A Haimeur et al.
CURRENT DRUG METABOLISM (2004)
ABCG2 -: a transporter for all seasons
B Sarkadi et al.
FEBS LETTERS (2004)
Strategies for reversing drug resistance
T Fojo et al.
ONCOGENE (2003)
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma
JC Bendell et al.
CANCER (2003)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Does resistance to apoptosis affect clinical response to antitumor drugs?
P Borst et al.
DRUG RESISTANCE UPDATES (2001)
Apoptosis is critical for drug response in vivo
CA Schmitt et al.
DRUG RESISTANCE UPDATES (2001)
Share Paper
